Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan José, Amenábar"'
Autor:
Francesc Moreso, Juan Oliver, Porfirio Pereira, Dámaso Sánz-Guajardo, Ernesto Gómez-Huertas, Javier Paul, Daniel Serón, Josep Crespo, Juan José Amenábar, Ricardo Lauzurica, Ángel Alonso Hernández, Beatriz Bayés
Publikováno v:
NDT Plus
Background. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II type 1 receptor blockers (ARB) decrease cardiovascular mortality and slow the progression of renal disease in non-transplant patients, but their impact on kidney transplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c0f445201509752047d61f5ec8007e
https://doi.org/10.1093/ndtplus/sfq068
https://doi.org/10.1093/ndtplus/sfq068
Autor:
Amado, Andrés, Roberto, Marcén, Francisco, Valdés, Jaime Sánchez, Plumed, Ricard, Solà, Pedro, Errasti, Ricardo, Lauzurica, Luis, Pallardó, Jesús, Bustamante, Juan José, Amenábar, Juan José, Plaza, Ernesto, Gómez, Josep Maria, Grinyó, Manuel, Rengel, Josep Maria, Puig, Aurelio, Sanz, Concepción, Asensio, Inés, Andrés, A, Osuna
Publikováno v:
Clinical Transplantation. 23:23-32
This study assays therapy with basiliximab and different patterns of cyclosporin A (CsA) initiation in renal transplant (RT) recipients from expanded criteria donors (ECD) and at high risk of delayed graft function (DGF). A multicentre six-month open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c420502ff1f3542e54f3c4845c86491a
https://doi.org/10.1111/j.1399-0012.2008.00891.x
https://doi.org/10.1111/j.1399-0012.2008.00891.x
Publikováno v:
Nefrologia; 2009 supplement 6, Vol. 29 Issue S6, p80-82, 3p